Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Vulvar Neoplasms × Circulating Tumor DNA × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Glioblastoma 2 Colorectal Neoplasms 2 Vulvar Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 Melanoma 1 Locally Advanced Rectal Carcinoma 1 Hypoxia 1 Gliosarcoma 1 Glioma 1 Genetic Diseases, Inborn 1 Esophageal Neoplasms 1 Circulating Tumor DNA 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Astrocytoma 1

Interventions

Methods 6 Surveys and Questionnaires 4 Radiotherapy 4 Cisplatin 4 pembrolizumab 3 Sentinel Lymph Node Biopsy 3 Radiosurgery 3 Palliative Care 3 Indocyanine Green 3 Early Intervention, Educational 3 Brachytherapy 3 Bleomycin 3 tremelimumab 2 durvalumab 2 Surgical Procedures, Operative 2 Radiation 2 Imiquimod 2 Gemcitabine 2 Electrochemotherapy 2 Drug Therapy 2 Dehydroepiandrosterone 2 Carboplatin 2 Biopsy 2 Bevacizumab 2 Behavior Therapy 2 zimberelimab 1 tivozanib 1 sapropterin 1 nanocis 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06582108 2024-09-03

ROAR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡